{"schema_version":"secwatch.filing_event.v1","accession":"0001553350-24-000088","form_type":"8-K","ticker":"TOI","cik":"0001799191","company_name":"Oncology Institute, Inc.","filed_at":"2024-09-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.556649+00:00","generated_at":"2026-05-31T02:28:59.768258+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"TOI CFO Mihir Shah resigns; Rob Carter promoted to CFO effective Oct 14","bullets":["CFO Mihir Shah resigns effective October 14, 2024, to pursue other opportunities; departure not related to operations or accounting policies.","Rob Carter, SVP of Finance since December 2021, promoted to CFO effective October 14, 2024; will serve as principal financial and accounting officer.","Carter brings over a decade of healthcare finance leadership, including roles at Hoag Health System, Kaiser Permanente, SCAN Health Plan, and McKesson.","Carter's initial base salary is $375,000 with a 40% target bonus; equity award to be granted on next regular quarterly grant date.","Shah will assist transition as an advisor under a consulting arrangement at an agreed hourly rate."],"urls":{"canonical":"https://secwatch.observer/filing/0001553350-24-000088","json":"https://secwatch.observer/filing/0001553350-24-000088.json","markdown":"https://secwatch.observer/filing/0001553350-24-000088.md","text":"https://secwatch.observer/filing/0001553350-24-000088.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799191/000155335024000088/0001553350-24-000088-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799191/000155335024000088/toi_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T02:28:59.768258+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4020b2c789","claim":"Robert Carter was appointed as Chief Financial Officer at Oncology Institute, Inc..","evidence_excerpt":"On September 20, 2024, the Company appointed Robert Carter to replace Mr. Shah as the Company’s Chief Financial Officer, with effect on October 14, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799191/000155335024000088/0001553350-24-000088-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"a8bc2790e8","claim":"Mihir Shah resigned as Chief Financial Officer at Oncology Institute, Inc..","evidence_excerpt":"On September 19, 2024, Mihir Shah, the Chief Financial Officer, principal financial officer, and principal accounting officer of The Oncology Institute, Inc. (the “Company”), delivered a notice of resignation effective as of October 14, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799191/000155335024000088/0001553350-24-000088-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}